Apply User Fees To Postmarket Data Collection In MDUFA IV, Pew Argues
This article was originally published in The Gray Sheet
Executive Summary
In the next round of MDUFA talks, FDA should target some industry user fees at gathering postmarket data, to support FDA’s growing emphasis on relying on postmarket data to resolve premarket uncertainties, Pew says in Aug. 12 comments.